Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Webster LK. Eur J Clin Pharmacol. Jan 1984; 27(3): 341-3
Pubmed [2427]
Wedam EF. Arch Intern Med. Dec 2007; 167(22): 2469-75
Pubmed [12]
Weddington WW Jr. Psychosomatics. Oct 1982; 23(10): 1076-8
Pubmed [7474]
Wee TC. Am J Phys Med Rehabil. Nov 2017; 96(11): e201-e203
Pubmed [4894]
Weeke P. Clin Pharmacol Ther. Jul 2012; 92(1): 72-9
Pubmed [12619]
Weemhoff JL. J Pharm Pharmacol. Mar 2003; 55(3): 381-6
Pubmed [8776]
Wegzyn CM. Curr Opin Pharmacol. Oct 2012; 12(5): 556-61
Pubmed [7207]
Wei L. BMJ. Sep 2011; 343: d5656
Pubmed [5314]
Wei X. J Pharmacol Exp Ther. May 1999; 289(2): 853-8
Pubmed [13764]
Wei Z. CNS Neurol Disord Drug Targets. Jan 2017; 16(7): 846-853
Pubmed [12310]
Weibrecht, Weigel. Dtsch Med Wochenschr (1976) 101, 20-2 [2406]
Weickert TW. Mol Psychiatry. Jun 2015; 20(6): 685-94
Pubmed [13439]
Weigmann H. Ther Drug Monit. Aug 2001; 23(4): 410-3
Pubmed [2300]
Weiler S, et al. BMJ. Sep 2013; 2: 200796
Pubmed [12915]
Weiler S. BMJ Case Rep. Sep 2013; 2013
Pubmed [12916]